There is no FDA-approved generic version of brand-name weight loss drugs since pharmaceutical companies still hold patents on ...

Why fork over thousands of dollars a month for prescription weight loss jabs when store-bought supplements claim to have the ...

As retail investors flock to Viking Therapeutics, the biotech firm is also catching the eye of billionaire fund managers like ...

Few medications have become as popular and culturally relevant as Ozempic has, but how exactly do it and similar drugs affect ...

Eli Lilly's long-term growth prospects are strong with improved supply, new growth opportunities, and competitive positioning ...

With a market capitalization of over $800 billion, Eli Lilly (NYSE: LLY) is the largest pharmaceutical company in the world.

High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...

According to Grand View Research, the global market for beauty and personal care products is projected to increase at a CAGR ...

According to Fortune Business Insights, in 2023, the hair care industry was estimated to be worth $99.52 billion globally.

The DRIPBaR Las Vegas offers a range of natural health solutions, specializing in therapies like High Dose Vitamin C for cancer support and GLP-1 peptides for sustainable weight loss. Their team of ...

Novo Nordisk, the manufacturer behind Ozempic and Wegovy, has another weight loss medication in the works with some ...

Pemvidutide's potential in obesity and MASH, combined with lean mass preservation, could make it a market leader in the ...